T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
C.H. Robinson
CHRW
$17.6B
| $169M | 0.02% |
1,574,588
-116,998
| -7% | -$11.4M |
|
602
Meritage Homes
MTH
$4.81B
| $169M | 0.02% |
2,769,440
-22,930
| -0.8% | -$1.28M |
|
|
AIV
603
Aimco
AIV
$378M
| $169M | 0.02% |
21,863,039
-427,033
| -2% | -$3.26M |
|
604
Pebblebrook Hotel Trust
PEB
$2.04B
| $168M | 0.02% |
7,519,561
-96
| -0% | -$2.16K |
|
605
Korn Ferry
KFY
$4.27B
| $168M | 0.02% |
2,219,732
-33,743
| -1% | -$2.59M |
|
606
Douglas Emmett
DEI
$1.98B
| $167M | 0.02% |
4,979,556
-4,293
| -0.1% | -$145K |
|
|
CTEV
607
Claritev Corp
CTEV
$631M
| $165M | 0.01% |
933,069
-410
| -0% | -$73K |
|
608
Ulta Beauty
ULTA
$22.2B
| $165M | 0.01% |
400,385
-565
| -0.1% | -$220K |
|
|
DCT
609
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $164M | 0.01% |
5,439,636
-730,193
| -12% | -$23.5M |
|
610
California Water Service
CWT
$3.12B
| $163M | 0.01% |
2,265,223
-84,967
| -4% | -$5.46M |
|
611
WSFS Financial
WSFS
$4.18B
| $162M | 0.01% |
3,237,267
-90,661
| -3% | -$4.75M |
|
612
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $162M | 0.01% |
4,581,082
-104,746
| -2% | -$3.75M |
|
613
NorthWestern Energy
NWE
$4.39B
| $162M | 0.01% |
2,833,636
-230,171
| -8% | -$13.1M |
|
614
KE Holdings
BEKE
$18.6B
| $161M | 0.01% |
8,013,735
+3,776,744
| +89% | +$77.4M |
|
|
NBIS
615
Nebius Group N.V.
NBIS
$68.9B
| $161M | 0.01% |
2,660,495
-93,843
| -3% | -$6.91M |
|
616
10x Genomics
TXG
$7.6B
| $160M | 0.01% |
1,077,212
+105,195
| +11% | +$16.1M |
|
617
Fox Class A
FOXA
$27.1B
| $160M | 0.01% |
4,342,581
-227,317
| -5% | -$8.96M |
|
618
PAR Technology
PAR
$744M
| $160M | 0.01% |
3,035,041
+20,375
| +0.7% | +$1.23M |
|
|
CSW
619
CSW Industrials
CSW
$5.64B
| $159M | 0.01% |
1,318,013
+4,591
| +0.3% | +$598K |
|
620
Gold Fields
GFI
$35.5B
| $159M | 0.01% |
14,486,682
-1,665,261
| -10% | -$16.6M |
|
621
Replimune Group
REPL
$1.45B
| $159M | 0.01% |
5,868,638
+151,598
| +3% | +$4.53M |
|
|
ATVI
622
DELISTED
Activision Blizzard
ATVI
| $157M | 0.01% |
2,364,696
+135,025
| +6% | +$9.23M |
|
623
Zebra Technologies
ZBRA
$17.9B
| $156M | 0.01% |
261,937
-533,720
| -67% | -$303M |
|
624
Wayfair
W
$14B
| $156M | 0.01% |
819,889
-215,525
| -21% | -$50.9M |
|
625
MGE Energy Inc
MGEE
$3.07B
| $156M | 0.01% |
1,892,539
-35,490
| -2% | -$2.73M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.